Surface localization of MPL36 and immunogenicity in humans. by Weinan Zhu (1640407)

Effects of varying RU486 exposure time on Aβ42 levels and toxicity. by Iain Rogers (152860)

“…(B) Soluble and insoluble Arctic Aβ42 was fractionated (see methods) and measured by ELISA at the indicated time-points (n = 3). …”

Associations of genetically determined iron status across the phenome: A mendelian randomization study by Dipender Gill (5514923)

“…After correcting for multiple testing, the 3 genetic instruments for systemic iron status demonstrated consistent evidence of a causal effect of higher iron status on decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard deviation [SD] increase in genetically determined serum iron levels 0.72, 95% confidence interval [CI] 0.64–0.81, <i>P</i> = 4 × 10⁻⁸) and hypercholesterolemia (hypercholesterolemia: OR 0.88, 95% CI 0.83–0.93, <i>P</i> = 2 × 10⁻⁵) and increasing risk of traits related to infection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10–1.42, <i>P</i> = 6 × 10⁻⁴). …”

Indices of tertiary industry activity (base year is 2015 and is set at 100) and the monthly number of newly confirmed COVID-19 cases. by Kenji Hibiya (96281)

VCP inhibition reduces AML cell growth and survival. by Paweł P. Szczęśniak (12359841)

Comparison of selected metabolites from significantly enriched metabolic sub-pathways. by Patrick C. Barko (10668358)

Change in movement behaviours over time. by Hugues Sampasa-Kanyinga (606145)

Effect of crizotinib (A-C) or alectinib (D-F) on firing rate of retinal ganglion cells. by Toshiyuki Ishii (53332)

“…The retina was repeatedly exposed to a set of light stimuli (1-s bright stimulation and 1-s dark stimulation at a frequency of 0.5 Hz). …”

Effect of O-ag modifying glycosyltransferases on complement activation and <i>Salmonella</i> interactions with human serum. by Fermin E. Guerra (6084545)

“…</i> Paratyphi A decrease complement activation as measured by C5a release and (B) IgM binding. …”

Expression of <i>pdcB</i> affects known c-di-GMP regulated processes. by Leila M. Reyes Ruiz (6690206)

Immunization of humanized mice with iDCgB protected against HCMV and promoted the persistence of long-term gB-specific functional memory CD8⁺ T cells and IgG⁺... by Sebastian J. Theobald (6001607)

“…<p><b>A)</b> Experimental scheme of iDCgB immunization and HCMV infection in humanized mice. …”

Differential Gene Expression by RamA in Ciprofloxacin-Resistant <em>Salmonella</em> Typhimurium by Jie Zheng (31208)

“…The PM analysis also uncovered that the <em>ramA</em> mutant was better in utilization of 10 carbon sources and 5 phosphorus sources. …”

Comparison of the DhaA tunnels identified by CAVER 3.0 with the previously proposed pathways. by Eva Chovancova (126086)

“…Decreasing the clustering threshold to 3.5 led to the separation of the p2a and p2b tunnels as well as the splitting of the p1 collective pathway into three clusters—p1a, p1a′ and p1b. …”

Long-term toxicity assessment. by Shen Huang (9967526)

Sensitivity analysis of time windows for TLCC. by Gabriel Carrasco-Escobar (794055)

Hyper-Hypo study: A Retrospective Observational Study of Neonatal Hypoglycemia Related to Maternal Hypertension by Thiruveni Ramkumar (17075051)

“…There was no significant difference in the mean initial blood glucose between neonates in the hypertensive versus non-hypertensive groups of mothers (1.7 vs 1.6 mmol/L). However, a sub-group comparison of neonates (with initial blood glucose <2.6 mmol/L) showed methyldopa to be marginally associated with a 2 mmol/L decrease from the mean initial blood glucose, mean 1.6 ± 0.5 mmol/L, and methyldopa (1.4 ± 0.5 mmol/L; p= .045). …”

Hierarchical clustering of COI samples reflects three spatially variable invertebrate assemblages dominated by copepod and cnidarian species. by Michelle E. Dan (18563775)

Mitochondrial damage induced by picornavirus infection. by Huisheng Liu (408091)

Associated with S4 Fig. by Erik Toraason (5724689)

Effect of Curcumin on Serum Urate in Asymptomatic Hyperuricemia: A Randomized Placebo-Controlled Trial by Pannipa Bupparenoo (8855129)

“…After 8 weeks, SU was significantly decreased in both groups (6.9% in curcumin group, <i>p</i> = 0.002, and 5.0% in placebo group, <i>p</i> = 0.009). …”